Cell-Based Systems Step Up: The Rise of Organoids,Organs-on-Chips,and More

Papes F , Camargo AP , de Souza JS , et al. Transcription factor 4 loss-of-function is associated with deficit in progenitor proliferation and cortical neuron content. Nat Commun, 2022; 13(1):2387; doi: 10.1038/s41467-022-29942-w.

Bioverativ. Proof-of-concept study for BIVV020 in chronic inflammatory demyelinating polyneuropathy (CIDP). Clinical Trial: NCT04658472. Available at https://clinicaltrials.gov/ct2/show/NCT04658472

Brownwell L . Cantex licenses intellectual property from Harvard University to develop repurposed drug identified by Wyss Institute to treat inflammatory lung diseases including COVID-19 . Wyss Institute . 2022. Available from: https://wyss.harvard.edu/news/cantex-licenses-intellectual-property-from-harvard-university-to-develop-repurposed-drug-identified-by-wyss-institute-to-treat-inflammatory-lung-diseases-including-covid-19 (Last accessed August 2, 2022).

Yucer N , Andoot R , Workman MJ , et al. Human iPSC-derived fallopian tube organoids with BRCA1 mutation recapitulate early-stage carcinogenesis. Cell Rep, 2021; 37(13):110146; doi: 10.1016/j.celrep.2021.110146.

Pietrobon A , Yockell-Lelievre J , Flood TA , et al. Renal organoid modeling of tuberous sclerosis complex reveals lesion features arise from diverse developmental processes. Cell Rep, 2022; 40(1):111048; doi: 10.1016/j.celrep.2022.111048.

Westerling-Bui A , Fast EM , Soare TW , et al. Transplanted organoids empower human preclinical assessment of drug candidate for the clinic. Sci Adv, 2022; 8:eabj5633; doi: 10.1126/sciadv.abj5633.

Rumsey JW , Lorance C , Jackson C , et al. Classical complement pathway inhibition in a “Human-On-A-Chip” model of autoimmune demyelinating neuropathies. Adv Ther, 2022; 5(6); doi: 10.1002/adtp.202200030.

Ewart L , Apostolou A , Briggs S , et al. Qualifying a human liver chip for predictive toxicology: Performance assessment and economic implications. bioRxiv, 2021; doi: 10.1101/2021.12.14.472674v3.

Ding S , Hsu C , Wang Z , et al. Patient-derived micro-organospheres enable clinical precision oncology. Cell Stem Cell, 2022; 29(6):905.e6–917.e6; doi: 10.1016/j.stem.2022.04.006.

Ingber DE . Human organs-on-chips for disease modeling, drug development and personalized medicine. Nat Rev Genet, 2022; 23;467–491. doi: 10.1038/s41576-022-00466-9.

Forsythe S , Erali R , Sasikumar S , et al. Organoid platform in preclinical investigation of personalized immunotherapy efficacy in appendiceal cancer: Feasibility study. Clin Cancer Res, 2021; 27:5141–5150; doi: 10.1158/1078-0432.CCR-21-0982.

Ahn SI , Sie YJ , Park H-J , et al. Microengineereed human blood-barrier platform for understanding nanoparticle transport mechanisms. Nat Commun, 2020; 11(1):175; doi: 10.1038/s41467-019-13896-7.

Gurumurthy RK , Kostr S , Kumar N , et al. Patient-derived and mouse endo-ectocervical organoid generation, genetic manipulation and applications to model infection. Nat Protoc, 2022; 17(7):1658–1690; doi: 10.1038/s41596-022-00695-6.

Watanabe S , Kobayshi S , Ogasawara N , et al. Transplantation of intestinal organoids into a mouse model of colitis. Nat Protoc, 2022; 17(3):649–671; doi: 10.1038/s41596-021-00658-3.

Mithal A , Hume AJ , Lindstrom-Vautrim J , et al. Human pluripotent stem cell-derived intestinal organoids model SARS-CoV-2 infection revealing a common epithelial inflammatory response. Stem Cell Reports, 2021; 16(4):940–953; doi: 10.1016/j.stemcr.2021.02.019.

Tiwari SK , Wang S , Smith D , et al. Revealing tissue-specific SARS-CoV-2 infection and host responses using human stem cell-derived lung and cerebral organoids. Stem Cell Reports, 2021; 16(3):437–445; doi: 10.1038/s41596-022-00695-6.

Rajan A , Weaver AM , Aloisio GM , et al. The human nose organoid respiratory virus model: An ex vivo human challenge model to study respiratory syncytial virus (RS) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pathogenesis and evaluate therapeutics. mBio, 2022; 13(1):e0351121; doi: 10.1128/mbio.03511-21.